Comparison of the Quality of Life among Patients with Idiopathic Thrombocytopenic Purpura and Healthy People in Isfahan, Iran
Journal Title: Iranian Journal of Blood and Cancer - Year 2014, Vol 7, Issue 1
Abstract
Background: Quality of life has been used as an important tool to understand illnesses impact in recent decades. Idiopathic thrombocytopenic purpura is a chronic disease which affects the individuals’ quality of life. The present study was conducted to compare the quality of life among idiopathic thrombocytopenic purpura patients’ with healthy people. Patients and Methods: This was a descriptive-comparative study with case and control groups. In this study, 64 randomly selected idiopathic thrombocytopenic purpura patients referred to Seyed Al-Shohada Hospital, Isfahan, Iran, and the same number of healthy people from the patients’ neighborhood as the control group, were compared considering their quality of life. The data collection tool used was the World Health Organization Quality of Life- BREF questionnaire. Results: Our study results showed that 64.1% of studied cases were older than 35 years of age, 59.4% were women, and most of them had primary educational level (53.1%). The mean scores of physical, mental, and environmental dimensions of quality of life and the total mean score of quality of life were significantly lower among idiopathic thrombocytopenic purpura patients (P < 0.001). However, there was no significant difference between the two groups in terms of the mean score of the social dimension of quality of life (P = 0.2). Conclusion: Since quality of life among idiopathic thrombocytopenic purpura patients is lower than that of healthy people, interventional therapeutic and care measures to promote quality of life among these patients seem necessary. Keywords: Quality of life, idiopathic thrombocytopenic purpura, Iran.
Authors and Affiliations
Z Hemati, D Kiani, F Mosavi
Keywords
Related Articles
- EP ID EP363260
- DOI -
- Views 92
- Downloads 0
A Case of Acute Myeloid Leukemia Caused by Low Dose Methotrexate Used to Treat a Rheumatoid Arthritis Patient
Methotrexate is an anti-rheumatic agent used as a first-line tretment for rheumatoid arthritis. Hematological malignancies like lymphoma or acute myeloid leukemia have been reported to be secondary to treatment with Meth...
Making plasma derived medicines available
Recent progress in past two decades in recombinant technology has created the opportunity of production of some of the plasma proteins including co -agulation factors using mammalian cell cultures. However, some limitati...
The levels of Serum Alkaline Phosphatase and Lactate Dehydrogenase in Hodgkin Lymphoma
Background: Hodgkin’s disease (HD) is a neoplastic disease originating in lymphoid tissue, which spreads to lymphoid structures and ultimately nonlymphoid tissues. Lactate Dehydrogenase and Alkaline Phosphatase are incre...
Frequency of Human Platelet Antigens (HPA-2/3/5) Polymorphism in Iranians Evaluated by RFLP-PCR
Background: Knowing the human platelet antigens (HPA) and genes frequency in different populations is important not only for population studies but also for clinical transfusion practice. HPA genes frequency in Iran is n...
Short-term Chelating Efficacy of Deferoxamine in Iron Overloaded Rat Hepatocytes
Abstract Background: Iron overload is a clinical consequence of repeated blood transfusions and causes significant organ damage, morbidity, and mortality in the absence of proper treatment. The primary targets of Iron ch...